Pharmacokinetics of W‐554 (ADD 03055) in Epileptic Patients

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Epilepsia

• Publication date

  1985-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1111/j.1528-1157.1985.tb05699.xPMID 4076064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptic Drugs (2nd ed)

  1984cited by this paper
• Simultaneous liquid-chromatographic determination of carbamazepine and its epoxide metabolite in plasma.

  1982cited by this paper
• Sensitive GLC procedure simultaneous determination of phenytoin and its major metabolite from plasma following single doses of phenytoin.

  1976cited by this paper

• Antiepileptic Drugs

  2020cites this paper
• Anticonvulsant Agents: Felbamate

  2020cites this paper
• Antiepileptic Drugs 89 Chapter 2 Antiepileptic Drugs

  2019cites this paper
• Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs

  2013cites this paper
• Antiepileptic Drug Therapy in Children

  2012cites this paper
• Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

  2008cites this paper
• Pharmacokinetic Variability of Newer Antiepileptic Drugs

  2006cites this paper
• Intoxikation durch Antiepileptika der neuen Generation

  2004influential citation
• Therapeutic Drug Monitoring of the Newer Antiepileptic Drugs

  2003cites this paper
• Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database.

  2003cites this paper
• In Vivo CYP3A4 Heteroactivation Is a Possible Mechanism for the Drug Interaction between Felbamate and Carbamazepine

  2003influential citation
• Proof of principle trials: exploratory open studies.

  2001cites this paper
• Pharmacologic management of epilepsy in the elderly.

  2001cites this paper
• New antiepileptic drugs.

  2000cites this paper
• Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies

  2000cites this paper
• The Clinical Pharmacokinetics of the New Antiepileptic Drugs

  1999cites this paper
• Coadministration of Phenytoin and Felbamate: Evidence of Additional Phenytoin Dose‐Reduction Requirements Based on Pharmacokinetics and Tolerability with Increasing Doses of Felbamate

  1999cites this paper
• Treatment of epilepsy in the elderly.

  1999cites this paper
• New Antiepileptic Drugs

  1999cites this paper
• Felbamate: clinical and molecular aspects of a unique antiepileptic drug.

  1998cites this paper
• Gc-ms analysis and post-mortem distribution of felbamate in humans

  1997cites this paper
• Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography.

  1997cites this paper
• Population pharmacokinetics of felbamate in children.

  1997cites this paper
• Determination of felbamate concentration in pediatric samples by high-performance liquid chromatography.

  1997cites this paper
• Clinical Trials for Antiepileptic Drugs: From Add-On to Monotherapy and Dose-Related Designs

  1997cites this paper
• Pharmacokinetic Interactions with Felbamate

  1997cites this paper
• Single‐Dose Pharmacokinetics and Effect of Food on the Bioavailability of Topiramate, A Novel Antiepileptic Drug

  1996cites this paper
• Felbamate Levels in Patients with Epilepsy

  1996cites this paper
• Pharmacokinetic Interactions of the New Antiepileptic Drugs

  1996cites this paper
• Totally automated analysis by robotized PrepStation and liquid chromatography: direct-sample analysis of felbamate.

  1996cites this paper
• Pharmacokinetic Interactions Between Antiepileptic Drugs

  1996cites this paper
• Pharmacokinetic Profile of Topiramate in Comparison with Other New Antiepileptic Drugs

  1996cites this paper
• The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.

  1996cites this paper
• Pharmacokinetics of New Antiepileptic Drugs

  1996cites this paper
• Pharmaceutical Care in a State Operated Mental Health and Developmental Disabilities Department

  1996cites this paper
• Management of Epilepsy in the Elderly

  1996cites this paper
• Management of Acute Anticonvulsant Overdose

  1996cites this paper
• Felbamate

  1995cites this paper
• Felbamate overdose: a case report and discussion of a new antiepileptic drug.

  1995cites this paper
• Isothermal Gas Chromatographic Method for the Rapid Determination of Felbamate Concentration in Human Serum

  1995cites this paper
• Clinical pharmacokinetics of new antiepileptic drugs.

  1995cites this paper
• The Place of Felbamate in the Treatment of Epilepsy

  1995cites this paper
• Felbamate Monotherapy: Implications for Antiepileptic Drug Development

  1995cites this paper
• Felbamate pharmacology and use in epilepsy.

  1994cites this paper
• New Antiepileptic Drugs

  1994cites this paper
• Das pharmakologische und klinische Profil des neuen Antiepileptikums Felbamat - eine Übersicht

  1994cites this paper
• New antiepileptic drugs

  1994cites this paper
• Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.

  1994cites this paper
• [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].

  1994cites this paper
• Felbamate: a new antiepileptic drug.

  1994cites this paper
• Newer Antiepileptic Drugs

  1994cites this paper
• The effect of felbamate on valproic acid disposition

  1994cites this paper
• Felbamate

  1993cites this paper
• Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.

  1993cites this paper
• Place of Newer Antiepileptic Drugs in the Treatment of Epilepsy

  1993cites this paper
• New antiepileptic medications.

  1993cites this paper
• Antiepileptic drugs in clinical development.

  1993cites this paper
• Advances in the Pharmacotherapy of Epilepsy

  1993cites this paper
• Prototype Antiepileptic Drug Clinical Development Plan

  1993cites this paper
• Protocol design.

  1993cites this paper
• Effect of felbamate on carbamazepine and its major metabolites

  1993cites this paper
• Comparative Pharmacokinetics of the Newer Antiepileptic Drugs

  1993cites this paper
• Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia‐ischemia

  1993cites this paper
• Felbamate

  1993cites this paper
• Protective Effects of Felbamate Against Hypoxia in the Rat Hippocampal Slice

  1992cites this paper
• A Neuropharmacological Evaluation of Felbamate as a Novel Anticonvulsant

  1992cites this paper
• Pharmacokinetics of Felbamate in Pediatric and Adult Beagle Dogs

  1992cites this paper
• Felbamate.

  1991cites this paper
• Discontinuation of Phenytoin and Carbamazepine in Patients Receiving Felbamate

  1991cites this paper
• Felbamate: A Clinical Trial for Complex Partial Seizures

  1991cites this paper
• Pharmacokinetics and interactions of the new antiepileptic drugs.

  1991cites this paper
• Felbamate for partial seizures

  1991cites this paper
• Felbamate pharmacokinetics in the rat, rabbit, and dog.

  1991cites this paper
• Antiepileptic Medications in Development

  1991cites this paper
• Felbamate in vitro metabolism by rat liver microsomes.

  1991cites this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cites this paper
• Simultaneous Assay of Felbamate plus Carbamazepine, Phenytoin, and Their Metabolites by Liquid Chromatography with Mobile Phase Optimization

  1990cites this paper
• Analysis of antiepileptic drugs.

  1990cites this paper
• Pharmacokinetic Drug Interactions with Phenytoin (Part II)

  1990cites this paper
• Pharmacokinetics of Felbamate, a Novel Antiepileptic Drug: Application of Mixed‐Effect Modeling to Clinical Trials

  1989cites this paper
• Effect of Felbamate on Phenytoin and Carbamazepine Serum Concentrations

  1989cites this paper
• Felbamate Increases Phenytoin but Decreases Carbamazepine Concentrations

  1988cites this paper